ALBIREO PHARMA INC (ALBO) Earnings History & Surprises
NASDAQ:ALBO • US01345P1066
44.15 USD
-0.1 (-0.23%)
At close: Mar 2, 2023
44.33 USD
+0.18 (+0.41%)
After Hours: 3/2/2023, 8:00:01 PM
Past quarterly earnings results for ALBIREO PHARMA INC (ALBO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 15, 2023
PeriodQ4 / 2022
EPS Estimate-$2.01
Revenue Estimate10.038M
Last Reported
Release DateFeb 27, 2023
PeriodQ3 / 2022
EPS Reported-$1.92
EPS Surprise -78.30%
Revenue Surprise 0.99%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -1.92 | -1.08 | -78.30% | 4.95% | 9.832M | 9.736M | 0.99% | 168.34% |
| Q2 2022 | -2.04 | -1.68 | -21.09% | -7.37% | 8.206M | 7.604M | 7.92% | 237.97% |
| Q1 2022 | -2.19 | -1.89 | -15.85% | 4.37% | 6.832M | 8.122M | -15.88% | 246.80% |
| Q4 2021 | -0.57 | -1.38 | 58.61% | 56.15% | 32.521M | 12.734M | 155.39% | 1,095.63% |
| Q3 2021 | -2.02 | -0.39 | -421.16% | -3.06% | 3.664M | 3.555M | 3.07% | 72.02% |
| Q2 2021 | -1.90 | -2.01 | 5.32% | -37.68% | 2.428M | 2.018M | 20.32% | 27.12% |
| Q1 2021 | -2.29 | -1.80 | -27.11% | -2.69% | 1.97M | 2.177M | -9.51% | 27.10% |
| Q4 2020 | -1.30 | -1.98 | 34.35% | - | 2.72M | 2.392M | 13.71% | - |
| Q3 2020 | -1.96 | -1.54 | -27.26% | - | 2.13M | 1.658M | 28.47% | - |
| Q2 2020 | -1.38 | -1.72 | 19.89% | - | 1.91M | 1.306M | 46.25% | - |
| Q1 2020 | -2.23 | -1.39 | -60.17% | - | 1.55M | 1.054M | 47.06% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-14.16%
Max EPS beat (4)
58.61%
Min EPS beat (4)
-78.30%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
37.10%
Max Revenue beat (4)
155.39%
Min Revenue beat (4)
-15.88%
Analysis
In the last 4 quarters, ALBO has beaten EPS estimates in 1 out of 4 releases
ALBO has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ALBO reported -14.2% below the EPS estimates on average.
In the last 4 quarters, ALBO has beaten the revenue estimates by 37.1% on average.
ALBIREO PHARMA INC / ALBO Earnings FAQ
When did ALBIREO PHARMA INC (ALBO) report earnings last quarter?
ALBIREO PHARMA INC (ALBO) last reported earnings on 2/27/2023.
Can you provide information on whether ALBIREO PHARMA INC beat earnings estimates in the last quarter?
ALBIREO PHARMA INC (ALBO) missed EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ALBO stock beat earnings estimates?
In the last 4 quarters, ALBIREO PHARMA INC (ALBO) has beaten EPS estimates in 1 out of 4 releases.